Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 7,601,087 | 7,601,087 | 0 | $605.43M | $739.21M | 52.02% | +$133.78M |
| Tyra Biosciences, Inc.(TYRA) | 4,055,861 | 4,055,861 | 0 | $106.63M | $155.34M | 10.93% | +$48.71M |
| Tango Therapeutics, Inc.(TNGX) | 7,266,081 | 7,266,081 | 0 | $64.38M | $152.01M | 10.70% | +$87.63M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 7,162,637 | 7,162,637 | 0 | $58.59M | $90.75M | 6.39% | +$32.16M |
| Alumis Inc | 2,915,998 | 3,540,998 | +625,000 | $28.46M | $78.01M | 5.49% | +$49.55M |
| Relay Therapeutics, Inc.(RLAY) | 4,701,506 | 5,526,506 | +825,000 | $39.77M | $54.99M | 3.87% | +$15.21M |
| Zymeworks Inc.(ZYME) | 1,113,946 | 1,113,946 | 0 | $29.33M | $27.89M | 1.96% | -$1.44M |
| Kymera Therapeutics, Inc.(KYMR) | 278,896 | 278,896 | 0 | $21.70M | $23.23M | 1.63% | +$1.53M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 4,449,932 | +4,449,932 | $0 | $20.91M | 1.47% | +$20.91M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,419,355 | 0 | $10.91M | $19.44M | 1.37% | +$8.53M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,141,145 | 1,141,145 | 0 | $11.81M | $16.22M | 1.14% | +$4.40M |
| Engene Holdings Inc COM | 2,124,943 | 2,324,943 | +200,000 | $19.19M | $15.83M | 1.11% | -$3.36M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 450,000 | +450,000 | $0 | $6.58M | 0.46% | +$6.58M |
| Arvinas, Inc.(ARVN) | 539,394 | 539,394 | 0 | $6.40M | $5.72M | 0.40% | -$679.6K |
| Silence Therapeutics plcADS(SLN) | 952,400 | 952,400 | 0 | $5.79M | $5.02M | 0.35% | -$771.4K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 279,237 | 304,237 | +25,000 | $4.38M | $5.00M | 0.35% | +$626.3K |
| ARS Pharmaceuticals, Inc.(SPRY) | 660,703 | 610,703 | -50,000 | $7.70M | $4.90M | 0.35% | -$2.79M |
| Mersana Therapeutics Inc | 482,689 | 0 | -482,689 | $13.96M | $0 | — | -$13.96M |